Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis
Status:
Not yet recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity
of subcutaneous SCT650C in patients with Axial Spondyloarthritis